13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Wilsons Disease
Wilson's Disease (also known as hepatolenticular degeneration) is an inherited disorder of copper metabolism that affects multiple organs including the liver, brain, and eyes. It is caused by a mutation of the ATP7B gene, which causes a buildup of copper in the body. This buildup of copper can lead to severe health problems such as cirrhosis of the liver, cognitive deficits, and eye disorders like Kayser-Fleischer rings. Symptoms often appear before adulthood, typically between ages 6 and 20. Common symptoms can include fatigue, lack of appetite, abdominal pain, jaundice, forgetfulness, speech difficulty, muscle spasms, difficulty controlling hand movement, and abnormal behavior. In later stages, Wilson's Disease may affect the brain, brain stems, and neurological systems, leading to more serious symptoms such as tremors, difficulty swallowing, seizures, and liver failure. Treatment for Wilson's Disease is aimed at reducing copper levels in the body and protecting organs from damage caused by the buildup of copper. Establishing a lifelong, comprehensive treatment plan is important for people with Wilson's Disease, as is regular monitoring of copper levels.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States